Randomised Clinical Trial: Addition of Alginate-Antacid (Gaviscon Double Action) to Proton Pump Inhibitor Therapy in Patients With Breakthrough Symptoms

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Retraction: Randomised Clinical Trial: The Clinical Efficacy and Safety of an Alginate-Antacid (Gaviscon Double Action) Versus Placebo, for Decreasing Upper Gastrointestinal Symptoms in Symptomatic Gastroesophageal Reflux Disease (GERD) in China by J. Sun

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Comparison of Daily Versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients With a Partial Response to Proton Pump Inhibitor Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Regression of Barrett’s Esophagus With Proton Pump Inhibitor Therapy

Progress of Digestive Endoscopy
2008English

Predictors of Response to Proton Pump Inhibitor Therapy Among Children With Significant Esophageal Eosinophilia

Pediatrics
Child HealthPediatricsPerinatology
2009English

Impedance-pH Monitoring in Proton Pump Inhibitor Resistant Patients: Ready for Clinical Application?

Gut
Gastroenterology
2006English

Proton Pump Inhibitor-Amoxicillin-Clarithromycin Versus Proton Pump Inhibitor-Amoxicillin-Metronidazole as First-Line Helicobacter Pylori Eradication Therapy

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2012English

Weight Loss Is Truly Effective in Reducing Symptoms and Proton Pump Inhibitor Use in Patients With Gastroesophageal Reflux Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Reducing Dyspeptic Symptoms in Children: Proton Pump Inhibitor vs. H2 Receptor Antagonist

Paediatrica Indonesiana
2014English

Choice of Optimal Proton Pump Inhibitor for Patients With Ischemic Heart Disease Who Require Dual Antiplatelet Therapy

HYPERTENSION
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy